DK1761478T3 - En isoleret Atomoxetin urenhed, fremgangsmåde til fremstilling af Atomoxetin urenheder og deres anvendelse som referencestandarder - Google Patents

En isoleret Atomoxetin urenhed, fremgangsmåde til fremstilling af Atomoxetin urenheder og deres anvendelse som referencestandarder

Info

Publication number
DK1761478T3
DK1761478T3 DK05771573T DK05771573T DK1761478T3 DK 1761478 T3 DK1761478 T3 DK 1761478T3 DK 05771573 T DK05771573 T DK 05771573T DK 05771573 T DK05771573 T DK 05771573T DK 1761478 T3 DK1761478 T3 DK 1761478T3
Authority
DK
Denmark
Prior art keywords
atomoxetine
impurity
impurities
isolated
producing
Prior art date
Application number
DK05771573T
Other languages
Danish (da)
English (en)
Inventor
Eugenio Castelli
Alessandra Vailati
Original Assignee
Teva Pharm Fine Chemicals Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharm Fine Chemicals Srl filed Critical Teva Pharm Fine Chemicals Srl
Application granted granted Critical
Publication of DK1761478T3 publication Critical patent/DK1761478T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/10—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/16—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring not being further substituted
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/06—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton from hydroxy amines by reactions involving the etherification or esterification of hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/48—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
DK05771573T 2004-06-28 2005-06-28 En isoleret Atomoxetin urenhed, fremgangsmåde til fremstilling af Atomoxetin urenheder og deres anvendelse som referencestandarder DK1761478T3 (da)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US58364104P 2004-06-28 2004-06-28
US58364404P 2004-06-28 2004-06-28
US58364304P 2004-06-28 2004-06-28
US60971604P 2004-09-14 2004-09-14
US62206504P 2004-10-25 2004-10-25
US65233005P 2005-02-11 2005-02-11
US65233205P 2005-02-11 2005-02-11
US65233105P 2005-02-11 2005-02-11
US66666605P 2005-03-30 2005-03-30
US67536905P 2005-04-26 2005-04-26
US68977805P 2005-06-09 2005-06-09
US69073805P 2005-06-14 2005-06-14
PCT/US2005/023423 WO2006004979A2 (en) 2004-06-28 2005-06-28 An isolated atomoxetine impurity, processes for the preparation of atomoxetine impurities and their use as reference standards

Publications (1)

Publication Number Publication Date
DK1761478T3 true DK1761478T3 (da) 2008-12-15

Family

ID=35783354

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05771573T DK1761478T3 (da) 2004-06-28 2005-06-28 En isoleret Atomoxetin urenhed, fremgangsmåde til fremstilling af Atomoxetin urenheder og deres anvendelse som referencestandarder

Country Status (11)

Country Link
US (5) US7355078B2 (ko)
EP (4) EP1682485A2 (ko)
JP (1) JP2008504302A (ko)
KR (2) KR20070001250A (ko)
AT (1) ATE407111T1 (ko)
CA (5) CA2560899A1 (ko)
DK (1) DK1761478T3 (ko)
ES (1) ES2313387T3 (ko)
IL (5) IL180353A0 (ko)
PL (1) PL1761478T3 (ko)
WO (5) WO2006068662A1 (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7439399B2 (en) 2004-06-28 2008-10-21 Teva Pharmaceutical Fine Chemicals Processes for the preparation of atomoxetine hydrochloride
DK1761478T3 (da) 2004-06-28 2008-12-15 Teva Pharm Fine Chemicals Srl En isoleret Atomoxetin urenhed, fremgangsmåde til fremstilling af Atomoxetin urenheder og deres anvendelse som referencestandarder
EP1768949A2 (en) 2004-07-22 2007-04-04 Teva Pharmaceutical Fine Chemicals S.R.L. Polymorphs of atomoxetiene hydrochloride
WO2006037055A1 (en) * 2004-09-27 2006-04-06 Dr. Reddy's Laboratories Ltd. Synthesis of atomoxetine hydrochloride
EP1751085A1 (en) * 2005-04-05 2007-02-14 Teva Pharmaceutical Fine Chemicals S.R.L. Stable atomoxetine hydrochloride, a process for the preparation thereof, and an analytical control of its stability
US8515185B2 (en) * 2009-11-25 2013-08-20 Google Inc. On-screen guideline-based selective text recognition
WO2011161690A1 (en) * 2010-06-23 2011-12-29 Symed Labs Limited Processes for the preparation of (+)-n,n-dimethyl-2-[1-(naphthalenyloxy) ethyl] benzene methanamine and intermediates thereof
WO2015001565A2 (en) * 2013-07-02 2015-01-08 Zcl Chemicals Limited "an improved process for the preparation of 3-aryloxy-3- phenylpropylamine and salt thereof"
CN104628768A (zh) * 2015-03-06 2015-05-20 江苏正大清江制药有限公司 一种伊班膦酸钠的制备方法
CN108929236A (zh) * 2017-05-26 2018-12-04 万特制药(海南)有限公司 盐酸托莫西汀的制备
CN110194719B (zh) * 2019-06-12 2020-05-15 山东大学 一种r-(-)-盐酸阿托莫西汀的制备方法
CN113336654B (zh) * 2020-02-18 2022-12-09 上海医药工业研究院 一种n-甲基-3-(2-甲基苯氧基)苯丙胺的制备方法
CN113358773B (zh) * 2021-05-21 2022-09-13 健民药业集团股份有限公司 一种检测盐酸托莫西汀对映异构体的反相液相色谱方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4194009A (en) * 1974-01-10 1980-03-18 Eli Lilly And Company Aryloxyphenylpropylamines for obtaining a psychotropic effect
US4018895A (en) 1974-01-10 1977-04-19 Eli Lilly And Company Aryloxyphenylpropylamines in treating depression
AU540707B2 (en) 1980-11-14 1984-11-29 Eli Lilly And Company N-methyl-3-(2methyl phenoxy)-o-phenylpropyl amine
US4777291A (en) * 1985-02-27 1988-10-11 Eli Lilly And Company Racemization process
DK630987D0 (da) * 1987-12-01 1987-12-01 Ferrosan As Aryloxyphenylpropylaminer, deres fremstilling og anvendelse
US4868344A (en) * 1988-03-30 1989-09-19 Aldrich-Boranes, Inc. Novel process of producing phenyl or substituted phenylalkylamine pharmaceutical agents and novel chiral intermediates of high enantiomeric purity useful therein
DE4123253A1 (de) 1991-07-15 1993-01-21 Schneider Manfred Prof Dr Verfahren zur enzymatischen racematspaltung halogenierter arylalkanole
HU9202128D0 (en) 1992-06-26 1992-10-28 Richter Gedeon Vegyeszet Method for producing n-methyl-(3-phenyl-3-(4-[trifluoro-methyl])-phenooxi-)-amine
US5658590A (en) 1995-01-11 1997-08-19 Eli Lilly And Company Treatment of attention-deficit/hyperactivity disorder
GB9812413D0 (en) 1998-06-10 1998-08-05 Glaxo Group Ltd Compound and its use
WO2000058262A1 (en) 1999-03-29 2000-10-05 Eli Lilly And Company Stereospecific method for preparing tomoxetine and intermediates thereof
WO2000061540A1 (en) 1999-04-09 2000-10-19 Eli Lilly And Company Methods for preparing 3-aryloxy-3-arylpropylamines and intermediates thereof
AU4010000A (en) * 1999-04-26 2000-11-10 Eli Lilly And Company Epimerization reaction for the production of r-fluoxetine
DK1761478T3 (da) 2004-06-28 2008-12-15 Teva Pharm Fine Chemicals Srl En isoleret Atomoxetin urenhed, fremgangsmåde til fremstilling af Atomoxetin urenheder og deres anvendelse som referencestandarder
EP1768949A2 (en) 2004-07-22 2007-04-04 Teva Pharmaceutical Fine Chemicals S.R.L. Polymorphs of atomoxetiene hydrochloride

Also Published As

Publication number Publication date
US7355078B2 (en) 2008-04-08
WO2006004976A3 (en) 2006-02-16
IL180355A0 (en) 2007-06-03
WO2006004976A2 (en) 2006-01-12
EP1704138A1 (en) 2006-09-27
WO2006004979A3 (en) 2006-04-13
US20060009530A1 (en) 2006-01-12
IL180353A0 (en) 2007-06-03
CA2561015A1 (en) 2006-06-29
IL180357A0 (en) 2007-06-03
CA2560899A1 (en) 2006-01-12
US20060009532A1 (en) 2006-01-12
PL1761478T3 (pl) 2009-04-30
EP1761478B1 (en) 2008-09-03
ES2313387T3 (es) 2009-03-01
US20060009489A1 (en) 2006-01-12
ATE407111T1 (de) 2008-09-15
EP1761478A2 (en) 2007-03-14
US7439398B2 (en) 2008-10-21
EP1682485A2 (en) 2006-07-26
US7317127B2 (en) 2008-01-08
WO2006068662A1 (en) 2006-06-29
KR20070001250A (ko) 2007-01-03
WO2006004979A2 (en) 2006-01-12
JP2008504302A (ja) 2008-02-14
WO2006004977A2 (en) 2006-01-12
KR20070057703A (ko) 2007-06-07
WO2006004923A2 (en) 2006-01-12
US7378553B2 (en) 2008-05-27
WO2006004923A3 (en) 2006-04-20
IL180354A0 (en) 2007-06-03
US20060009531A1 (en) 2006-01-12
CA2561387A1 (en) 2006-01-12
WO2006004977A3 (en) 2006-04-13
CA2561386A1 (en) 2006-01-12
IL180356A0 (en) 2007-06-03
US7507861B2 (en) 2009-03-24
CA2561866A1 (en) 2006-01-12
EP1687254A2 (en) 2006-08-09
US20060009490A1 (en) 2006-01-12

Similar Documents

Publication Publication Date Title
DK1761478T3 (da) En isoleret Atomoxetin urenhed, fremgangsmåde til fremstilling af Atomoxetin urenheder og deres anvendelse som referencestandarder
WO2006027705A3 (en) Synthesis of triethylenetetramines
UA93861C2 (uk) Спосіб одержання n-фенілпіразол-1-карбоксамідів та сполука аніліну
UA95600C2 (en) Synthesis scheme for lacosamide
UA100367C2 (uk) Спосіб одержання мемантину і його гідрохлориду
EA200700673A1 (ru) Твердая фармацевтическая композиция, содержащая донепезила гидрохлорид
EA200870038A1 (ru) Способ получения аминов
TW200612959A (en) Method for preparing hydroxamic acids
EA200700550A1 (ru) Производные алкилидентетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
HRP20090103T3 (en) Method for preparing 4 -amino-4'-demethyl-4-desoxypodophyllotoxin
TW200738650A (en) Process for synthesis of aryloxy diaminopyrimidines
NO20076307L (no) Fremgangsmater for a fremstille biarylurinstoffer og analoger derav
EA200600977A1 (ru) Способы получения венлафаксина и формы i венлафаксина гидрохлорида
MXPA05013604A (es) Procedimiento para preparar acilsulfamoilbenzamidas.
BRPI0519785A2 (pt) processo para a preparação de isocianatos de tiofenossulfonila
TW200621734A (en) Process for preparing diarylcycloalkyl derivatives
MX2007008125A (es) Procedimiento para preparar aminas benciladas.
EA200601563A1 (ru) Водно-изопропанольный сольват оланзапина
EA200800044A1 (ru) Производные 2,5-бисдиамин[1,4]бензохинона
ATE417055T1 (de) Steroid modifizierte solatriosen
ITMI20040582A1 (it) Processo per la semisintesi di deserpidina
UA88160C2 (ru) Водно-изопропанольный сольват оланзапина, способ его получения и способ получения формы и оланзапина
TW200626525A (en) Synthesis of polyamine compounds
WO2009037230A3 (en) Improved process for preparing (e)-2-(2-chloromethylphenyl)-2-alkoximinoacetic esters
MXPA05013690A (es) Procedimiento para preparar sildenafil.